Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent medical guidelines emphasize the importance of actively treating overweight and obesity with diet and lifestyle intervention to achieve ≥ 5% weight loss in a 6-month period. Commercial programs offer one approach provided there is evidence of their efficacy and safety. This study was conducted to evaluate the effectiveness of the Medifast® 4 & 2 & 1 Plan™ on weight loss, body composition and cardiometabolic risk factors in overweight and obese adults. METHODS: A systematic retrospective chart review of 310 overweight and obese clients following the Medifast 4 & 2 & 1 Plan at one of 21 Medifast Weight Control Centers® was conducted. Data were recorded electronically and key data points were independently verified. The primary endpoint was change from baseline body weight at 12 weeks. Within group paired t-tests were used to examine changes from baseline in a completers population. Differences between gender and age subgroups were examined using bivariate t-tests and mixed model regression analyses. RESULTS: For the primary endpoint at 12 weeks, body weight among completers (n = 185) was reduced by a mean of 10.9 ± 5.6 kg (-10.1%, p < 0.0001), and at 24 weeks (n = 81) mean weight was reduced by 16.0 ± 7.9 kg (-14.3%). At 12 and 24 weeks, 85% and 96% of those remaining on the plan, respectively, had lost ≥ 5% of their baseline body weight. Lean mass was preserved to within 5% of baseline throughout the 24 weeks, and fat mass represented ≥ 80% of the body weight lost from 12 weeks onward. Men, women, seniors (≥ 65 years), and non-seniors (<65 years) all had significant weight reductions with preservation of lean mass. Significant improvements in blood pressure, pulse and waist-to-hip ratio were observed. Mean weight regain among the subset who entered a formal maintenance phase was <2% during an average follow-up of 34 weeks. The meal plan was well tolerated, and program adherence was >85%. CONCLUSIONS: The 4 & 2 & 1 Plan used at Medifast Weight Control Centers was effective for weight loss, preservation of lean mass and improvement in cardiometabolic risk factors. The plan was generally well tolerated in a broad population of overweight and obese adults. #NCT02150837.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“VLCDs are very effective at achieving weight loss and significant improvement in cardiometabolic parameters in short periods [221,222], including diabetes remission”
From Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment (2025) · cites this paper as [222]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072 · cited 1×
“overweight and 35 % are obese [2].”
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580 · cited 1×
“3 % [4, 5].”
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Prevalence of obesity in the United States, 2009-2010.
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2012) · PubMed · Cited by 2,444
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828 · cited 1×
“For overweight or obese individuals, even a relatively small amount of weight loss can reduce the risk of developing related co-morbidities, such as cardiovascular disease, type 2 diabetes and some forms of cancers [1, 8–11].”
BackgroundGadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60205-5 · Cited by 1,064 · cited 1×
“Indeed, the observed rate of serious events is similar to placebo rates observed in pharmacotherapy trials with similar populations [47–49].”
ResultUS Department of Health & Human Services; Public Health Service; Office of Surgeon General (2001) · PsycEXTRA Dataset · doi:10.1037/e301232004-001 · Cited by 1,001
Multicenter, placebo-controlled trial of lorcaserin for weight management.
Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911 · cited 1×
“Indeed, the observed rate of serious events is similar to placebo rates observed in pharmacotherapy trials with similar populations [47–49].”
Result(2008) · Encyclopedia of Obesity · doi:10.4135/9781412963862.n17 · Cited by 861
Research works printed but not linked: 1
- Njeze GE. Gallstones. Nigeria: Nigerian Journal of Surgery; 2013.
Cited by
Vest, A. R., Chan, M., Deswal, A., Givertz, M. M., Lekavich, C., Lennie, T., Litwin, S. E., Parsly, L., Rodgers, J. E., Rich, M. W., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.03.007 · Cited by 230
“Meal replacement programs, eg, with high-protein shakes, may help to support short- and medium-term weight loss.(52) Cardiovascular obesity management guidelines recommend a diet of 1200 1500 kcal/d for women and 1500 1800 kcal/d for men without endorsing any specific dietary strategies, but they do recommend a person…”
BackgroundValidation of a portable bioelectrical impedance analyzer for the assessment of body composition
Karelis, A. D., Chamberland, G., Aubertin-Leheudre, M., Duval, C., & Ecological mobility in Aging and Parkinson (EMAP) group (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0129 · Cited by 124
“38: 27–32 (2013) dx.”
Jakše, B., Pinter, S., Jakše, B., Bučar Pajek, M., & Pajek, J. (2017) · BioMed Research International · doi:10.1155/2017/9626390 · Cited by 96
“Inclusion of meal replacements may therefore represent one of the solutions for improving the long-term success of weight-reducing diets in free-living subjects [17, 18].”
BackgroundVenkatakrishnan, K., Chiu, H., & Wang, C. (2019) · Food & Function · doi:10.1039/c9fo00293f · Cited by 85
Moldovan, C. P., Weldon, A. J., Daher, N. S., Schneider, L. E., Bellinger, D. L., Berk, L. S., Hermé, A. C., Aréchiga, A. L., Davis, W. L., & Peters, W. R. (2016) · Obesity · doi:10.1002/oby.21649 · Cited by 55
“The InBody 230 was used in a previous study that examined weight loss with Medifast MRS (29).”
Method
Metadata
- Authors
- Coleman, C. D., Kiel, J. R., Mitola, A. H., Langford, J. S., Davis, K. N., & Arterburn, L. M.
- Affiliations
- Medifast, Inc. (United States) (US)
- Corresponding author
- Coleman, Christopher D.
- Venue
- Nutrition Journal
- Published
- 2015-08-06
- Volume
- 14
- Issue
- 1
- Pages
- 77-77
- ISSN
- 1475-2891 (ISSN-L)
- PMC
- PMC4527127
- OpenAlex
- W1922250856
- Cited by
- 34
- References
- 55
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 1 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 5 · 2016: 1 · 2015: 1
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrition Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- meal replacement, weight loss, obesity, overweight adults, body composition, lean mass preservation, fat loss, cardiometabolic risk factors, blood pressure, waist-to-hip ratio, weight regain, program adherence, commercial weight loss programs, weight maintenance, gender differences, age differences, older adults
- MeSH terms
- Adult, Aged, Body Composition, Body Weight, Cardiovascular Diseases, Diet, Diet, Reducing, Female, Follow-Up Studies, Humans, Life Style, Male, Middle Aged, Obesity, Retrospective Studies, Risk Factors, Body Mass Index, Metabolic Syndrome, Overweight, Meals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study. https://app.cochat.ai/papers/10.1186/s12937-015-0062-8
- The paper
- Coleman, C. D., Kiel, J. R., Mitola, A. H., Langford, J. S., Davis, K. N., & Arterburn, L. M. (2015). Effectiveness of a Medifast meal replacement program on weight, body composition and cardiometabolic risk factors in overweight and obese adults: a multicenter systematic retrospective chart review study. Nutrition Journal. https://doi.org/10.1186/s12937-015-0062-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.